Changes in High Sensitive C Reactive Protien With Different Treatment Modalities in Acute Pancreatitis
Launched by ASSIUT UNIVERSITY · Nov 9, 2018
Trial Information
Current as of July 25, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age\>=18 years
- * Diagnosis of acute pancreatitis confirmed by at least 2 of the following:
- • 1. Typical epigastric abdominal pain
- • 2. Elevation amylase/lipase \>3 times upper limit normal and/or
- • 3. Confirmatory findings on cross-sectional imaging
- • 4. Enrollment within 8 hours of presentation
- Exclusion Criteria:
- • Class II or greater NYHA heart failure
- • Oxygen dependent COPD
- • Chronic kidney disease\>stage 2
- • Existing necrosis on abdominal CT
- • Organ dysfunction prior to enrollment
- • Sepsis
- • Acute respiratory distress syndrome
- • Malignancy not in remission for at least 5 years
- • Active drug use
- • Known allergy to dexamethasone
- • Altered mental status
- • Insulin-requiring diabetes
- • Abdominal surgery within 60days
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Assuit, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials